Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds

Cultured primary progenitor cell types are worthy therapeutic candidates for regenerative medicine. Clinical translation, industrial transposition, and commercial implementation of products based on such cell sources are mainly hindered by economic or technical barriers and stringent regulatory requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Alexis, Lin, Poyin, Scaletta, Corinne, Hirt-Burri, Nathalie, Michetti, Murielle, de Buys Roessingh, Anthony S., Raffoul, Wassim, She, Bin-Ru, Applegate, Lee Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317026/
https://www.ncbi.nlm.nih.gov/pubmed/32637400
http://dx.doi.org/10.3389/fbioe.2020.00581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317026/
https://www.ncbi.nlm.nih.gov/pubmed/32637400
http://dx.doi.org/10.3389/fbioe.2020.00581

Ejemplares similares